NO955011D0 - Intracellular binding proteins and their use - Google Patents

Intracellular binding proteins and their use

Info

Publication number
NO955011D0
NO955011D0 NO955011A NO955011A NO955011D0 NO 955011 D0 NO955011 D0 NO 955011D0 NO 955011 A NO955011 A NO 955011A NO 955011 A NO955011 A NO 955011A NO 955011 D0 NO955011 D0 NO 955011D0
Authority
NO
Norway
Prior art keywords
pct
binding proteins
date dec
sec
nucleic acid
Prior art date
Application number
NO955011A
Other languages
Norwegian (no)
Other versions
NO955011L (en
NO319466B1 (en
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO955011L publication Critical patent/NO955011L/en
Publication of NO955011D0 publication Critical patent/NO955011D0/en
Publication of NO319466B1 publication Critical patent/NO319466B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1072—Regulatory proteins, e.g. tat, rev, vpt
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

PCT No. PCT/FR94/00714 Sec. 371 Date Dec. 28, 1995 Sec. 102(e) Date Dec. 28, 1995 PCT Filed Jun. 15, 1994 PCT Pub. No. WO94/29446 PCT Pub. Date Dec. 22, 1994The present invention relates to nucleic acid sequences encoding intracellular binding proteins. More particularly, the nucleic acid comprises a gene coding for an intracellular single chain antibody specific for a ras oncogene under the control of a promoter, the antibody is functional in mammalian cells, and inhibits the transformation of cells that express a ras oncogene.
NO19955011A 1993-06-16 1995-12-11 Nucleic acid sequence encoding intracellular binding proteins and defect, recombinant virus, vector, pharmaceutical preparation and use thereof. NO319466B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307241A FR2706486B1 (en) 1993-06-16 1993-06-16 Nucleic sequences, vectors containing them, pharmaceutical compositions and therapeutic uses.
PCT/FR1994/000714 WO1994029446A2 (en) 1993-06-16 1994-06-15 Intracellular binding proteins and use thereof

Publications (3)

Publication Number Publication Date
NO955011L NO955011L (en) 1995-12-11
NO955011D0 true NO955011D0 (en) 1995-12-11
NO319466B1 NO319466B1 (en) 2005-08-15

Family

ID=9448183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19955011A NO319466B1 (en) 1993-06-16 1995-12-11 Nucleic acid sequence encoding intracellular binding proteins and defect, recombinant virus, vector, pharmaceutical preparation and use thereof.

Country Status (24)

Country Link
US (1) US6159947A (en)
EP (1) EP0703980B1 (en)
JP (1) JP4384260B2 (en)
KR (1) KR100342233B1 (en)
CN (1) CN1076052C (en)
AT (1) ATE231916T1 (en)
AU (1) AU7076394A (en)
BR (1) BR9407512A (en)
CA (1) CA2165458C (en)
CZ (1) CZ289039B6 (en)
DE (1) DE69432075T2 (en)
DK (1) DK0703980T3 (en)
ES (1) ES2191031T3 (en)
FI (1) FI120311B (en)
FR (1) FR2706486B1 (en)
HU (1) HU219138B (en)
NO (1) NO319466B1 (en)
NZ (1) NZ268038A (en)
PL (1) PL180760B1 (en)
RU (1) RU2218400C2 (en)
SK (1) SK285169B6 (en)
UA (1) UA46709C2 (en)
WO (1) WO1994029446A2 (en)
ZA (1) ZA944303B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790633B1 (en) * 1990-04-18 2004-09-14 Michael S. Brown Method of inhibiting a farnesyl transferase enzyme
US8003342B1 (en) 1990-04-18 2011-08-23 Board Of Regents, The University Of Texas System Method for identifying farnesyl transferase inhibitors
FR2724320B1 (en) * 1994-09-13 1996-12-20 Transgene Sa NEW IMPLANT FOR THE TREATMENT OF ACQUIRED DISEASES
US5518042A (en) * 1994-09-16 1996-05-21 Huyck Licensco, Inc. Papermaker's forming fabric with additional cross machine direction locator and fiber supporting yarns
FR2738151B1 (en) * 1995-09-04 1997-09-26 Rhone Poulenc Rorer Sa ANTAGONISTS OF THE ONCOGENIC ACTIVITY OF THE MDM2 PROTEIN, AND THEIR USE IN THE TREATMENT OF CANCERS
CZ299055B6 (en) * 1996-12-06 2008-04-09 Aventis Pharmaceuticals Inc. Isolated polypeptide encoded by a lipase like gene, composition having phospholipase activity, pharmaceutical composition, isolated immunizing peptide and nucleic acid, biologically compatible solution, vector, recombinant cell, formulation useable f
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
FR2758569B1 (en) * 1997-01-20 1999-04-02 Centre Nat Rech Scient BIOLOGICAL MATERIAL FOR THE TREATMENT OF A MAMMAL BY TRANSFERRING ANTIBODY GENE AND PHARMACEUTICAL COMPOSITION CONCERNING THE SAME
AU3604800A (en) * 1999-02-26 2000-09-14 Mindset Biopharmaceuticals (Usa) Ltd. Method for regulating the stability of recombinant proteins, and antibodies and products useful therein
FR2794771B1 (en) 1999-06-11 2001-08-10 Aventis Pharma Sa RECOMBINANT ADENOVIRUSES ENCODING THE IODINE SPECIFIC TRANSPORTER (NIS)
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
WO2001074900A2 (en) 2000-03-31 2001-10-11 Aventis Pharmaceuticals Products Inc. Nuclear factor kb inducing factor
WO2002086096A2 (en) * 2001-01-23 2002-10-31 University Of Rochester Medical Center Methods of producing or identifying intrabodies in eukaryotic cells
US9328142B2 (en) 2011-05-25 2016-05-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lipopeptide inhibitors of RAS oncoproteins
KR101602870B1 (en) 2014-07-22 2016-03-21 아주대학교산학협력단 Method for Cell-penetrating and cytosol-localizing of intact immunoglobulin antibody, and use thereof
KR101602876B1 (en) 2014-07-22 2016-03-11 아주대학교산학협력단 Method for inhibiting activated RAS using intact immunoglobulin antibody having Cell-penetrating ability and use thereof
US20180072815A1 (en) 2014-10-23 2018-03-15 Singh Biotechnology, Llc Single Domain Antibodies Directed Against Intracellular Antigens
KR102207382B1 (en) * 2014-10-23 2021-01-27 싱 몰레큘러 메디신, 엘엘씨 Single domain antibodies directed against intracellular antigens
TWI746473B (en) 2015-11-02 2021-11-21 美商辛分子醫藥有限公司 Single domain antibodies directed against intracellular antigens
WO2017204606A1 (en) 2016-05-27 2017-11-30 오름테라퓨틱 주식회사 Cytosol-penetrating antibody and use thereof
KR20190143826A (en) 2018-06-21 2019-12-31 오름테라퓨틱 주식회사 Cell/tissue-specific cell-penetrating antibodies
CN110981943B (en) * 2019-12-02 2021-08-03 清华大学 Polypeptide, application thereof in preparation of medicine and medicine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
DE3915952A1 (en) * 1989-05-12 1990-12-06 Peter Werner Medicaments for treating diseases involving intracellular protein - comprising nucleic acid coding for antibody to protein
WO1992005250A1 (en) * 1990-09-25 1992-04-02 University Of Connecticut Prolonging expression of polynucleotides introduced into a cell
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
AU675413B2 (en) * 1991-09-30 1997-02-06 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Recombinant immunotoxins
CA2125396A1 (en) * 1991-12-10 1993-06-24 Wayne A. Marasco Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof
DE69334095T2 (en) * 1992-07-17 2007-04-12 Dana-Farber Cancer Institute, Boston Method for intracellular binding of targeted molecules

Also Published As

Publication number Publication date
WO1994029446A3 (en) 1995-02-02
DE69432075T2 (en) 2003-09-04
HUT74266A (en) 1996-11-28
JPH08511162A (en) 1996-11-26
FI956057A0 (en) 1995-12-15
HU9503615D0 (en) 1996-02-28
CZ289039B6 (en) 2001-10-17
PL180760B1 (en) 2001-04-30
FR2706486B1 (en) 1995-09-01
SK285169B6 (en) 2006-07-07
WO1994029446A2 (en) 1994-12-22
NO955011L (en) 1995-12-11
SK156895A3 (en) 1996-05-08
ATE231916T1 (en) 2003-02-15
HU219138B (en) 2001-02-28
EP0703980A1 (en) 1996-04-03
UA46709C2 (en) 2002-06-17
CA2165458C (en) 2011-05-10
PL312213A1 (en) 1996-04-01
EP0703980B1 (en) 2003-01-29
FI120311B (en) 2009-09-15
ES2191031T3 (en) 2003-09-01
AU7076394A (en) 1995-01-03
ZA944303B (en) 1995-02-14
DE69432075D1 (en) 2003-03-06
DK0703980T3 (en) 2003-05-19
CA2165458A1 (en) 1994-12-22
KR100342233B1 (en) 2002-12-05
CZ329595A3 (en) 1996-03-13
FI956057A (en) 1995-12-15
FR2706486A1 (en) 1994-12-23
BR9407512A (en) 1997-01-07
JP4384260B2 (en) 2009-12-16
RU2218400C2 (en) 2003-12-10
US6159947A (en) 2000-12-12
NZ268038A (en) 1997-12-19
CN1126491A (en) 1996-07-10
CN1076052C (en) 2001-12-12
NO319466B1 (en) 2005-08-15

Similar Documents

Publication Publication Date Title
NO955011D0 (en) Intracellular binding proteins and their use
ATE400651T1 (en) USE OF GREEN FLUORESCENT PROTEIN
FI934811A (en) STABILIZER ENZYMER OCH DETERGENTFOERENINGAR
ATE348175T1 (en) METHOD OF INTRACELLULAR BINDING OF TARGETED MOLECULES
WO1996039429A3 (en) Serum protein produced exclusively in adipocytes
ATE239036T1 (en) RECOMBINANT CORE STREPTAVIDIN
FI942442A0 (en) Production of proteins using 7B2 protein
DK0719328T3 (en) Genet GRB 3-3, variants thereof and their use
FI952094A0 (en) DNA encoding the human serotonin receptor (5-HT4B) and its use
NO972313D0 (en) Peptides capable of binding to the GAP protein SH3 region, nucleotide sequences encoding this, and their production and use
ATE274351T1 (en) USE OF ISOLATED DOMAIN OF TYPE IV COLLAGEN TO ALTER CELL AND TISSUE INTERACTION
DK0773999T3 (en) OR-1, an orphan receptor belonging to the nuclear receptor family
IT1275909B1 (en) FRAGMENT OF DNA CODING D-AMINO ACID OXIDASE
DK0788549T3 (en) Regulatory nucleic acid sequences and applications
DK0778347T3 (en) Protein with putative helicase and ATPase properties that bind ATP and nucleic acid
WO2002074957A3 (en) Stress-responsive activator of p300 (strap) protein
DE59611353D1 (en) TRANSKETOLASE-RELATED PROTEIN

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees